Documents & Downloads

Pirsidomine

Sydnonimine Compound

Pirsidomine is a sydnonimine compound that serves as a nitric oxide donor. It has the ability to convert into a nitric oxide-releasing metabolite in vivo, demonstrating significant effects on cardiovascular physiology. In preclinical models, Pirsidomine effectively prevents occlusion-induced increases in flow in non-occluded coronary arteries and markedly reduces blood flow in non-ischemic areas during myocardial infarction studies. This compound is valuable for research applications focused on cardiovascular diseases.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	132722-74-8
Applications	Sydnonimine Compound
Formula	C₁₇H₂₂N₄O₃
Molecular Weight	330.38
SMILES	C[C@H]1N([N+]2=NOC([N-]C(C3=CC=C(OC)C=C3)=O)=C2)[C@H](CCC1)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.